Your session is about to expire
← Back to Search
Intraocular Lens
Tecnis MF for Cataract
Phase 4
Waitlist Available
Led By William Trattler, MD
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
The purpose of this study is to compare the visual outcomes with bilateral implantation of Tecnis MF and ReSTOR IOLs Six months post cataract surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Distance Visual Acuities
Intermediate Acuities
Near Visual Acuities
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Tecnis MFExperimental Treatment1 Intervention
Group II: ReSTORExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tecnis MF
2009
Completed Phase 4
~110
ReSTOR
2007
Completed Phase 4
~580
Find a Location
Who is running the clinical trial?
Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,568 Total Patients Enrolled
14 Trials studying Cataract
532 Patients Enrolled for Cataract
William Trattler, MDPrincipal InvestigatorThe Center for Excellence in Eye Care
11 Previous Clinical Trials
6,539 Total Patients Enrolled
3 Trials studying Cataract
300 Patients Enrolled for Cataract
Larry Katzen, MDPrincipal InvestigatorKatzen Eye Care & Laser Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger